series-b
Stage
2021
Founded
1
Investors
About
Aera Therapeutics develops next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, focusing on targeted lipid nanoparticles, antibody oligonucleotide conjugates, and protein nanoparticles to treat various diseases.
Explore Aera Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.